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Besides the mnnomcric mammalian 95 kDa progelatinase, two additional forms, ~1 disulfide-bridged 220 kDa dinxr and a 125 kDn form were 
isolated from human PMN Icukocytes. The I25 kDa progelatinase was identified as a covalcntly linked, disul!!de-bridged hetcrodimer formed of 
the monomer with a 2s kDa protein. This 25 kDa protein was isolntcd from pclatinase bound to the atIinity support of gelatin-Scpharosc and 
eluted by DTE-containing bulli3r. The amino acid sequence of tryptic peptides of this protein rcvenled homology with an c+-microglobulin-related 
protein from rats, a protein so far unknown in humans. 
Gelotinnsc; rr,-Microglobulin-relnted protein; Mctalloproteinase; Lipocalin 
1. INTRODUCTION 
95 kDa gelatinase, or matrix melaHoproteinase-9 
(MMP-9), is a neutral metalloproteinase which has been 
isolated from neutrophils, macrophages and trans- 
formed fibroblasts. Gelatinase degrades a number of 
matrix components, including elastin [1], cartilage pro- 
teoglycan [l], collagen types IV [2], V [3], XI [1] and type 
I gelatin. 
MMP-9 has the most complex domain structure of all 
members of the matrix metalloproteinese family. In ad- 
dition to the signal peptide (not in the mature protein), 
the propeptide, the catalytic and the C-terminal he- 
mopexin-like domain are a Bbronectin-homologous re- 
gion inserted into the catalytic domain, and a type V 
collagen-homologous region inserted in the C-terminal 
domain [4]. The flbronectin-like domain can bind gela- 
tin [S], a fact with practical application for the purifica- 
tion of gelatinase, but without relevance for substrate 
specifity [6]. The type V collagen-like domain contains 
I cysteine residue, which is assumed to participate in the 
dimerization of gelatinase [2]. A special feature of 
MMP-9 isolated from neutrophils is that it exists par- 
tially in higher molecular weight forms. Neutrophils 
secrete the monomeric 95 kDa form, a reduction-sensi- 
tive 220 kD@ homodimer and 125 kDa heterodimer. 
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Here we report on the isolation of the disulfide-linked 
25 kDa protein from the heterodimer. Determination of 
parts of the amino acid sequence revealed homology to 
an a2-microglobulin-related protein from rats, so far 
not discovered in humans. 
2. MATERIALS AND METHODS 
Endoglycosidasc FIN-glycosidase F was purchased from Boehrin- 
ger-Mannheim Biochcmica (Germany) and TPCK-treated trypsin was 
from Merck (Darmstadt. Germany). Plasmatonin was a gift from 
Fresenius (Oberursel, Gomuny). 
2.1. lsolutiorr utid pwificariorr OJ PMNL prog&tDlasc 
PMNL progelatinase was isolated ~15 published elsewhere [7] as a 
mixture ofthree molecular mass forms (220, 125 and 95 kDn). Sepnm- 
tion of free progelutinase and progelatinase-TIMP-1 complex was 
achieved by hcparin-Sepharose cbromntography as described by 
Kolkenbrock [6] for the 72 kDa gclatinnsc and its complex with TIMP- 
2. 
2.2, Seprrrrion ox the 25 kDn protebr 
TlMP-l-free progelatinase was adsorbed to a gelatin-Sepharose 
column. Elution with burfer A (50 mM Tris-MCI, pH 7.5, 1 M NnCI, 
5 mM CaQ, 0.02% NairlJ containing 10 mM DTE, yicldcxl the 
reduced 25 kDa protein. The 9s kDa geletinase wns eluted with buCfcr 
A containing 2.5% DMSO. 
2.3. Curbo.~~~nrcrf~ylation of rhe 25 kDa poreit 
10 mg gelatinase mixture was dialysLvl against 0.1 N acetic acid, 
lyophilieed and dissolved in 2.5 ml buffer B (0.5 M Tris-I-ICI, pH 8.1, 
6 M guonidinc hydrochloride, 2 mM EDTA). The solution was incu- 
bated under argon atmosphere for 30 min at 50°C. Then 5 mg DTE 
was added under argon atmosphere and the solution was incubated 
for a further 3 h at 50DC. 13 mg iodoocetamide dissolved in buffer B 
were added at room temperature and incubattil in the dark for 30 min. 
The iC;Ciitil E%CC WRS dirCct:y sub$Ctcd to an FPLC gc!-6!tration 
column yielding pure carboxymethylnted 25 kDa protein and the car- 
boxymethyhtted progclatinase. 
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2.4. Charactcrisution wrd itfcrtt~catior~ of the 25 kDo protelr~ 
2.4. I. Deglycosylation with endoglycosidase F 
1,000 ~1 carboxamidomethylatcd 25kDa protein were lyophilized 
and dissolved in buffer C (100 mM K3POJ*M20, PI-I 6.5, 50 mM 
EDTA, 1% Triton X-100). After 5 min healing at 100°C I pl endogly 
cosidase F was added and incubalcd for 2 days at 37’C. 
2.4.2. Cleavage by trypsin 
1.5 ml 25 kDa protein was dialyzed against buffer D (20 mM 
Tris-HCI, pH 8,1 M NaCI) and incubntcd overnight with IpI TPCK- 
treated trypsin. The reaction mixture was concentrated and directly 
subjected to HPLC on a 33nkcrbond Cl8 wide-pore reverse-phase col- 
umn. The pcptidev were isolnted at a constant flow ralc of 0.8 mUmin 
using a linear gradient of O-80% acetonitrile, and further subjected to 
automated amino acid sequence determination. 
3. RESULTS AND DISCUSSION 
Analysis of the gelatinase preparation from PMN 
leukocytes by SDS-PAGE showed 3 protein bands with 
apparent molecular weights of 220, 125 and 95 kDa [G]. 
The N-termini of the different gelatinase forms were 
found to be identical and were the same as that of the 
proenzyme from SV-40-transformed lung fibroblasts 
[a]. All 3 forms showed no activity against the synthetic 
DNP octapeptide prior to activation. Under reducing 
conditions in SDS-PAGE these forms resulted in a 95 
and 25 kDa protein band [6]. Consequently the 25 kDa 
protein could be isolated from progelatinase bound to 
gelatin-Sepharose by reducing buffer. The N-terminus 
of this protein was blocked against Edman degradation. 
The isolation of tryptic peptides of the carbaxymethyl- 
ated 25 kDa protein allowed the the first sequence infor- 
mation to be obtained. Comparison of the sequence 
data with that of proteins of the EMBL protein data- 
base revealed homology to an c+microglobulin-related 
protein from rats [9] (Fig. 1). Homology to this family 
of proteins was supported by similarity in molecular 
weights. Deglycosylation by endoglycosidase F reduced 
the molecular weight of the human 25 kDa glycoprotein 
by removal of the N-glycosidic-bound oligosaccharides 
to 22 kDa (Fig. 2). This compared well to the 22.6 kDa 
estimated from the cDNA for the rat protein. 
The secretion of high molecular weight gelatinase 
forms is a special feature of PMN leukocytes. Macro- 
phagcs [lo] and transformed cell lines [2] produce only 
the monomeric form. The physiological roles of the 
homodimer and the heterodimer are still unknown. Re- 
cently, a 130 kDa gelatinolytic enzyme has been found 
to participate in involution of the mammary gland of 
rats [l 11. Besides this, Backstrom et al. [Ia] identified a 
gelatinolytic enzyme with the same molecular weight in 
Alzheimer-aff&ted hippocampus tissue of humans. Our 
characterization of the heterodimer may facilitate the 
determination of its physiological role. The protein to 
which the 25 kDa protein is homologous has been char- 
acterized, in so far that the mRNA amount in the liver 
and prostate of male rats is the same, but lower in the 
4 MGLGVLCLAL VLLGVLQRQA QDSTQNLIPA PPLISVPLQP Gy;;ERFOGR 
EEASSTRG pJ AKL NGD 
4 GDVP TPPDNIQVQE NFNISRlYGK 
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1 SGAYCKTDTD GKFLYHKSKW NITME ZV vt4 TNYDEYAf FLTKKFSRHH 
1 ~YFKVTLYGR SLG LPENIIIVFPV PIDP??P 
2 QYFKVTLYGR TKGLSDELKE RFVSFAKSLG LKDNNIVFSV PTDQCIDN 
3 TFQLMVLYGR TKDLSSDIKE LFAKLCERHG ITRDNILDLT KTDRCLPARG 
4 GPTITAKLYG RAPQLRETLL QDFRVVAQGV GIPEDSIFTM ADRGECVPGE 
: 
3 
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Fig. I. Comparison of the amino acid sequences of(l) &microglob- 
ulin-r&ted protein from humans idcntificd as a component of the 125 
kDa form of gelntinase, (2) a,-microglobulin-reiatcd protein from rats 
[14]. (3) c+microglobulin from rxts [14], (4) a,-microglobulin from 
humans [l4]. The underlined regions indicate those sequences used to 
identify homologies within Ihe family of lipocatins. 
liver of females [S]. The question of whether the PMN 
leukocytes of male and female humans contain the same 
amounts of the 125 kDa gelatinase will be the subject 
of future investigations. The protein to which the rat 
protein is related, &-microglobulin, is the major urinary 
protein of sexually mature rats, but it is not expressed 
by humans [13]. It is produced in the liver and involved 
in hyaline droplet nephropathy. Its exact role in normal 
physiology is not understood at present. 
On the basis of amino acid sequence homology, G+ 
microglobulin has been allocated to the group of pro- 
96 
67 
Fig. 2, Demonstration fthe molecular weights beforeand afkrdegly- 
covlation (10% SDS-PAGE, silver stained). Lane 1. mrkcr proteins: 
lane 2, endoglycosidase F (A), glycosylated a3-micro&lobulin-rclatcd 
protein (B), deglycosylated a,-microglobulin-rclatcd protein (C); lane 
3, a,-microglobulin-related protein without endoglycosidase. 
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Fig. 3. Isolation of the a,-microglobulin-related protein (10% SDS- 
PAGE, silver stained). Lane 1, marker proteins; lane 2, different gclati- 
nasc forms, (A) 125 kDa, (B) 95 kDa monomer; lane 3, different 
gclatinasc forms under reducing conditions, (D) 95 kDa monomer and 
a,-microglobulin-related protein; lane 4, az-microglobulin-related 
protein after gelatin-Sepharosc and dialysis ngninst non-reducing 
buffer, dimer (C) and monomer (II); lane 5, carboxymethylatcd a?- 
microglobulin-related protein (D). 
teins called lipocalins [14]. This protein family includes 
proteins such as retinol binding protein [IS], al-acid 
glycoprotein [lG], complement C8y [17] and a,-mi- 
croglobulin [lS], all identified in human urine or serum. 
The common feature of all lipocalins is their capacity 
to transport small lipophilic ligands through the hydro- 
philic body fluid [13]. Some members, based on their 
odd cystcine number, could be isolated as disulflde- 
linked heterodimers with other proteins. In humans, 
a,-microgiobulin was found as a heterodimer with IgA 
[17] and C8y bound to CSa in human complement C8
elc]* 
Fig. 3 shows the lipocalin protein isolated by us 
bound to neutrophil gelatinase. The free form isolated 
under reducing conditions dimerized during oxidation. 
Disulfide-linked homodimers and heterodimers are still 
unknown in the other members of the matrix metal- 
loproteinase family. All have two conserved cysteine 
residues in the hemopexin-like domain, which arc as- 
sumed to be disulfide bridged [14]. Recently we found 
that these cysteines and one additional cysteine in this 
domain of PMNL gelatinase are not disulfide linked 
[19]. This may be the basis of homodimer and heterod- 
imer formation. 
The physiological significance of the connection be- 
tween the metalloproteinase and the lipocalin families 
cstnb!ishcd ty a m ~C!P~iiXX.C x,-;;;iCrog!ot;‘~!in-rc!a:ed 
protein heterodimer will be the subject of further inves- 
tigations. The lipocalin protein showed neither inhibitor 
nor activator activity against gelatinase, as deter.mined 
by degradation of synthetic DNP octapeptide. Some 
lipocalin proteins are also known to transport retinol 
through the hydrophilic body fluid [13]. Furthermore, 
it has been shown recently [20-Z] that retinoic acid can 
modulate the secretion of TIMP and the metallopro- 
teinases. Whether the a,-microglobulin-related protein 
can participate in similar processes remains unknown at 
present. a,-Microglobulin, a closely related protein, has 
been found to affect the chemotaxis of neutrophils [23]. 
It will soon be shown whether the new lipocalin member 
has any effect on human neutrophils. 
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